Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

NCT05642208 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis
Eczema, Atopic

Interventions

DRUG: Dupilumab step-down

Sponsor

Nantes University Hospital